The Nuffield Early Language Intervention

Evaluation Report

Published in: Education Endowment Foundation (2020)

Posted on on May 05, 2020

by Sashka Dimova, Sonia Ilie, Elena Rosa Brown, Miriam Broeks, Andreas Culora, Alex Sutherland

Read More

Access further information on this document at

This article was published outside of RAND. The full text of the article can be found at the link above.

The Nuffield Early Language Intervention (NELI) programme is designed to improve the language skills of reception pupils (aged 4–5) and involves scripted individual and small-group language teaching sessions delivered by trained teaching assistants (TAs). NELI is published by Oxford University Press and was delivered in this trial by the University of Oxford in partnership with Elklan. The 20-week intervention consists of two 15-minute individual sessions and three 30-minute small group sessions each week. The children selected to participate in this trial were the five children in each classroom who obtained the lowest scores on a school-administered app-based assessment of oral language skills (LanguageScreen).

The programme focuses on developing children's narrative, vocabulary, and listening skills, while phonological awareness and letter sound knowledge are also developed during the second half of the programme. Training includes an initial two-day course for TAs followed by a half-day workshop half-way through the programme in addition to ongoing online support. Teachers also receive an initial half-day of training so that they can understand the programme and support TAs.

This project was a randomised controlled trial; 193 schools participated, 97 of which received the programme while 96 did not, the latter forming the control group. The process evaluation involved observations of the training, surveys with school staff, case studies in six schools (which used interviews with school staff), and analyses of TA training logs and online resource use. This project was co-funded with the financial support of Intermediate Capital Group (ICG). The trial took place between June 2018 and November 2019.

Research conducted by

This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

Our mission to help improve policy and decisionmaking through research and analysis is enabled through our core values of quality and objectivity and our unwavering commitment to the highest level of integrity and ethical behavior. To help ensure our research and analysis are rigorous, objective, and nonpartisan, we subject our research publications to a robust and exacting quality-assurance process; avoid both the appearance and reality of financial and other conflicts of interest through staff training, project screening, and a policy of mandatory disclosure; and pursue transparency in our research engagements through our commitment to the open publication of our research findings and recommendations, disclosure of the source of funding of published research, and policies to ensure intellectual independence. For more information, visit

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.